{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:35:50Z","timestamp":1784709350499,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.11.075","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T06:15:59Z","timestamp":1511763359000},"page":"306-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Novel triazine dimers with potent antitrypanosomal activity"],"prefix":"10.1016","volume":"143","author":[{"given":"Muthusamy","family":"Venkatraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8261-3489","authenticated-orcid":false,"given":"Irene G.","family":"Salado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Heeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Joossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Lewi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van der Veken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5203-4339","authenticated-orcid":false,"given":"Koen","family":"Augustyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejmech.2017.11.075_bib1","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania","volume":"52","author":"Cavalli","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.075_bib2","author":"Organization"},{"issue":"9709","key":"10.1016\/j.ejmech.2017.11.075_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejmech.2017.11.075_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"issue":"5","key":"10.1016\/j.ejmech.2017.11.075_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.qco.0000244045.93016.b1","article-title":"New developments in human African trypanosomiasis","volume":"19","author":"Brun","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ejmech.2017.11.075_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13550280802282934","article-title":"Traversal of human and animal trypanosomes across the blood-brain barrier","volume":"14","author":"Grab","year":"2008","journal-title":"J.\u00a0Neurovirol."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2017.11.075_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"Delespaux","year":"2007","journal-title":"Drug Resist. Update."},{"issue":"5","key":"10.1016\/j.ejmech.2017.11.075_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A\u00a0current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathog. Glob. Health"},{"issue":"7","key":"10.1016\/j.ejmech.2017.11.075_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"20","key":"10.1016\/j.ejmech.2017.11.075_bib10","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/jm400362b","article-title":"Drug discovery for neglected diseases: molecular target-based and phenotypic approaches","volume":"56","author":"Gilbert","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2017.11.075_bib11","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1016\/j.bmc.2011.08.060","article-title":"Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"19","author":"Venkatraj","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2017.11.075_bib12","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1016\/j.bmcl.2012.09.066","article-title":"Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents","volume":"22","author":"Venkatraj","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2017.11.075_bib13","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/jac\/dkt166","article-title":"Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission","volume":"68","author":"Arien","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2017.11.075_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2014.08.054","article-title":"Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398","volume":"475","author":"Grammen","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"49","key":"10.1016\/j.ejmech.2017.11.075_bib15","doi-asserted-by":"crossref","first-page":"34028","DOI":"10.1074\/jbc.M109.049726","article-title":"Predictive computational models of substrate binding by a nucleoside transporter","volume":"284","author":"Collar","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2017.11.075_bib16","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.bmc.2014.08.005","article-title":"From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds","volume":"22","author":"Venkatraj","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2017.11.075_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1179\/136485906X118495","article-title":"Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia","volume":"100","author":"Bermudez","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2017.11.075_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm00001a026","article-title":"Synthesis and activity of some antimalarial bisquinolines","volume":"38","author":"Raynes","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2017.11.075_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1128\/AAC.41.3.677","article-title":"Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S, S enantiomer, Ro 47-7737","volume":"41","author":"Ridley","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2017.11.075_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bmc.2010.11.036","article-title":"Synthesis, antiprotozoal, antimicrobial, beta-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines)","volume":"19","author":"Kaur","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2017.11.075_bib21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/jm030974c","article-title":"Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin","volume":"47","author":"Jeyadevan","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2017.11.075_bib22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/jm701168h","article-title":"Malaria-infected mice are cured by oral administration of new artemisinin derivatives","volume":"51","author":"Posner","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2017.11.075_bib23","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1016\/j.bmc.2009.10.019","article-title":"Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers","volume":"17","author":"Slade","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2017.11.075_bib24","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm990946n","article-title":"Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis(9-amino-6-chloro-2-methoxyacridines): influence of the linker","volume":"43","author":"Girault","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2017.11.075_bib25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1021\/jm0310840","article-title":"Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines","volume":"47","author":"Guillon","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2017.11.075_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00436-014-4210-4","article-title":"Anti-trypanosomal activities and structural chemical properties of selected compound classes","volume":"114","author":"Ponte-Sucre","year":"2015","journal-title":"Parasitol. Res."},{"issue":"16","key":"10.1016\/j.ejmech.2017.11.075_bib27","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.bmc.2016.06.003","article-title":"Bistacrine derivatives as new potent antimalarials","volume":"24","author":"Schmidt","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2017.11.075_bib28","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.bmcl.2008.03.020","article-title":"Novel bisbenzimidazoles with antileishmanial effectiveness","volume":"18","author":"Mayence","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.ejmech.2017.11.075_bib29","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1016\/j.bmc.2011.10.039","article-title":"Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agents","volume":"19","author":"Mayence","year":"2011","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417309790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417309790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T21:38:48Z","timestamp":1540417128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417309790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"alternative-id":["S0223523417309790"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.075","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel triazine dimers with potent antitrypanosomal activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}